units, negative urine and feces, PSP excretion 40% in 15mins. and 70% in 2 hrs., negative cerebrospinal fluid, PBI 5.3ug/100ml, thyroidal 131I-uptake 23.4% per 24 hrs., red cell uptake of negative bone and skull X-ray and irregular alpha-waves of 8 to 9c/s interspersed with sharp and wave complex in the occipital region and continuous wave in the frontal area with positive build up upon hyperventilation in the EEG, suggesting symptomatic epilepsy. "Parathyroid Injection"
(Eli Lilly), 50 units per m2 body surface injected intravenously, failed to cause a significant phosphaturia whereas the same preparation caused a 3 to 4 folds increase in urinary phosphorus excretion in normal children (Table 1) . Intravenous infusion of 15mg/kg calcium in the form of gluconate dissolved in 400ml physiological saline over a period of 4hrs. caused a 16% drop of urinary phosphorus excretion in the next 24hrs., while serum phosphorus was raised 3.1mg/100ml 4hrs. after the end of the infusion (Table 2) . Intelligence quotient was 86 according to Tanaka-Binet's method.
Parathyroid hormone-like activity in urine was assayed after extracting the urine with benzoic acid `adsorption (Fujita et al., 1961) followed by purification with XE-64 ion-exchange resin and assayed by 32P excretion in parathyroidectomized rats (Fujita et al., 1961) and elevation of serum (Munson, 1961) . Parathyroid hormonelike calcium-mobilizing activity was 56 USP units/24 hr. during AT-10 administration and 118 and 64 units 7 and 10 days after discontinuation respectively, while corresponding values averaged 15 units in 6 normal subjects. Parathyroid homone-like phosphaturic activity, on the other hand, stayed within normal limits of 30 units/24 hr.; 26 units/24 hr. during AT-10 administration and 22 and 10 units 7 days and 10 days after discontinuation respectively (Table 3) .
Treatment with 3 g of calcium lactate and 30, 000 units of vitamin D2 per day failed to restore serum calcium to normal and the convulsions kept to occur with intervals of about 10 days. Administration of 2ml per day of AT-10, started in November, completely abolished the convulsions and restored the serum calcium and phosphorus to normal (Fig.  3) . Continuation of AT-10 medication last two and half years successfully controled the clinical picture and patient grew 11cm during the 1 year 10 month period. Administration of 2ml per day of AT-10, started in November, completely abolished the convulsions and restored the serum calcium and phosphorus to normal after about 6 weeks. The diagnosis of pseudohypoparathyroidism in this case was based upon the increased neuromuscular excitability resulting in convulsive seizures, round face and short stature, subcutaneous calcification, low intelligence, hypocalcemia, hyperphosphatemia negative response to exogenous parathyroid extract, and normal response to calcium infusion. Although the physiological significance of urinary parathyroid hormone-like activity has not been established as yet due to the inherent difficulty in the method of extraction and bioassay, the increase in calciummobilizing activity at least suggests the presence of some parathyroid hormone-like activity in the organism in contradistinction from idiopathic hypoparathyroidism.
In view of the absence of detectable amount of parathyroid hormone-like calcium-mobilizing activity in half of the normal subjects studied, parathyroid hyperfunction in pseudohypoparathyroidism as suggested by Kolb (1962) remains an interesting possibility. Costello (1963) has presented a 6 year old girl with biochemical hypoparathyroidism and X-ray picture of hyperparathyroidism but without the physical characterisitics of pseudohypoparathyroidism, suggesting a new syndrome of hypo-hyperparathyroidism.
The present case apparently does not belong to this category in view of the almost complete clinical picture of pseudohypoparathyroidism.
Bioassay of parathyroid hormone-like activity in urine might be of value in distinguishing between idiopathic hypoparathyroidism and pseudohypoparthyroidism. 
